|Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR …|
D Jayne, A Pigazzi, H Marshall, J Croft, N Corrigan, J Copeland, P Quirke, ...
Jama 318 (16), 1569-1580, 2017
|PET-CT surveillance versus neck dissection in advanced head and neck cancer|
H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...
New England Journal of Medicine 374 (15), 1444-1454, 2016
|Who will care? Employment participation and willingness to supply informal care|
F Carmichael, S Charles, C Hulme
Journal of health economics 29 (1), 182-190, 2010
|Workplace physical activity interventions: a systematic review|
L Dugdill, A Brettle, C Hulme, S McCluskey, AF Long
International Journal of Workplace Health Management, 2008
|Non‐pharmacological approaches for dementia that informal carers might try or access: a systematic review|
C Hulme, J Wright, T Crocker, Y Oluboyede, A House
International journal of geriatric psychiatry 25 (7), 756-763, 2010
|A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-á) inhibitors, adalimumab and infliximab, for Crohn's disease.|
J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, ...
Health Technology Assessment (Winchester, England) 15 (6), 1, 2011
|Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review|
C Kelly, C Hulme, T Farragher, G Clarke
BMJ open 6 (11), 2016
|The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis|
LC Coates, N Navarro-Coy, SR Brown, S Brown, L McParland, H Collier, ...
BMC musculoskeletal disorders 14 (1), 101, 2013
|Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome|
SJ Bowman, CC Everett, JL O'Dwyer, P Emery, C Pitzalis, WF Ng, ...
Arthritis & Rheumatology 69 (7), 1440-1450, 2017
|The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk|
TA Fairbairn, DM Meads, C Hulme, AN Mather, S Plein, DJ Blackman, ...
Heart 99 (13), 914-920, 2013
|Giving older workers a voice: constraints on the employment of older people in the North West of England|
L Porcellato, F Carmichael, C Hulme, B Ingham, A Prashar
Work, Employment and Society 24 (1), 85-103, 2010
|A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons|
AM Bagnall, J South, C Hulme, J Woodall, K Vinall-Collier, G Raine, ...
BMC Public Health 15 (1), 290, 2015
|Work–life imbalance: Informal care and paid employment in the UK|
F Carmichael, C Hulme, S Sheppard, G Connell
Feminist Economics 14 (2), 3-35, 2008
|PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): randomised phase 3 non-inferiority trial with …|
HM Earl, L Hiller, AL Vallier, S Loi, D Howe, HB Higgins, K McAdam, ...
Journal of Clinical Oncology 36 (15_suppl), 506-506, 2018
|6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial|
HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...
The Lancet 393 (10191), 2599-2612, 2019
|What is the cost of a healthy diet? Using diet data from the UK Women's Cohort Study|
MA Morris, C Hulme, GP Clarke, KL Edwards, JE Cade
J Epidemiol Community Health 68 (11), 1043-1049, 2014
|Updated cost-effectiveness analysis of trastuzumab for early breast cancer|
PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron
Pharmacoeconomics 29 (5), 415-432, 2011
|Cost effectiveness modelling for health technology assessment: a practical course|
R Edlin, C McCabe, C Hulme, P Hall, J Wright
|Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial|
J Bartlett, P Canney, A Campbell, D Cameron, J Donovan, J Dunn, H Earl, ...
Clinical oncology 25 (2), 109-116, 2013
|Urinary tract infections in children and the risk of ESRF|
J Round, AC Fitzgerald, C Hulme, M Lakhanpaul, K Tullus
Acta Paediatrica 101 (3), 278-282, 2012